Correlation Between Denali Therapeutics and Rapport Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Denali Therapeutics and Rapport Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Denali Therapeutics and Rapport Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Denali Therapeutics and Rapport Therapeutics, Common, you can compare the effects of market volatilities on Denali Therapeutics and Rapport Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Denali Therapeutics with a short position of Rapport Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Denali Therapeutics and Rapport Therapeutics,.
Diversification Opportunities for Denali Therapeutics and Rapport Therapeutics,
0.56 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Denali and Rapport is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Denali Therapeutics and Rapport Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rapport Therapeutics, and Denali Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Denali Therapeutics are associated (or correlated) with Rapport Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rapport Therapeutics, has no effect on the direction of Denali Therapeutics i.e., Denali Therapeutics and Rapport Therapeutics, go up and down completely randomly.
Pair Corralation between Denali Therapeutics and Rapport Therapeutics,
Given the investment horizon of 90 days Denali Therapeutics is expected to generate 0.98 times more return on investment than Rapport Therapeutics,. However, Denali Therapeutics is 1.02 times less risky than Rapport Therapeutics,. It trades about 0.08 of its potential returns per unit of risk. Rapport Therapeutics, Common is currently generating about -0.29 per unit of risk. If you would invest 2,078 in Denali Therapeutics on October 24, 2024 and sell it today you would earn a total of 115.00 from holding Denali Therapeutics or generate 5.53% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Denali Therapeutics vs. Rapport Therapeutics, Common
Performance |
| Timeline |
| Denali Therapeutics |
| Rapport Therapeutics, |
Denali Therapeutics and Rapport Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Denali Therapeutics and Rapport Therapeutics,
The main advantage of trading using opposite Denali Therapeutics and Rapport Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Denali Therapeutics position performs unexpectedly, Rapport Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rapport Therapeutics, will offset losses from the drop in Rapport Therapeutics,'s long position.| Denali Therapeutics vs. Stoke Therapeutics | Denali Therapeutics vs. Black Diamond Therapeutics | Denali Therapeutics vs. 4D Molecular Therapeutics | Denali Therapeutics vs. Ascendis Pharma AS |
| Rapport Therapeutics, vs. Genesco | Rapport Therapeutics, vs. Skechers USA | Rapport Therapeutics, vs. Bridgford Foods | Rapport Therapeutics, vs. Sysco |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |